Dr. Langer is a Professor of Medicine at the University of Pennsylvania Perelman School of Medicine in the Division of Hematology-Oncology, where he is the Co-Director of the Interdisciplinary Thoracic Oncology Program (I-TOP). His research expertise includes combined modality therapy of locally advanced NSCLC and Head and Neck Cancer (HNC), the evaluation of new agents in advanced NSCLC, with particular attention to neglected populations, including the elderly and in patients with compromised performance status, and the role of re-irradiation in combination with systemic therapy. More recent work has focused on the multi-targeted antifols; nano-particle bound taxanes; monoclonal antibodies targeting EGFr and other receptors; and immunotherapy. He is also involved in Penn’s Center for Personalized Diagnostics. Dr. Langer maintains a leadership role in the RTOG/NRG Cooperative Oncology Group, where he chairs the Medical Oncology Subcommittee, and is active in the Thoracic and HNC Committees of both ECOG and NRG.